Dr Vijay Chandru to continue as Strand’s Chairman
Strand Life Sciences, a global genomic profiling company announced the appointment of Scott A. Storrer as Chief Executive Officer. In his expanded role, he will be responsible for all strategy, business expansion and worldwide operations effective immediately. Dr Vijay Chandru, who has served as Strand’s Chairman and CEO since its founding in 2000, will continue in his role as Chairman of the board of directors.
“Scott’s twenty-plus years of executive experience leading and growing profitable businesses in the healthcare industry across the payer, provider and personalised medicine sectors will help Strand develop a strong presence globally,” Chandru said. “His move into our CEO post following me reflects the planned progression of our company and shift in focus to new products for use by physicians. I am excited to work with him and our board members as we build a dominant market position for StrandAdvantage.”
Storrer added, “Strand is at a significant point in its global expansion and product roll-out. We recently introduced a new version of StrandAdvantage that features a panel that examines 152 genes — all genes and pathways known to be impacted by existing targeted cancer therapies plus additional chemotherapeutic toxicity and resistance data. I look forward to making this important development in genomic testing widely available to oncologists and pathologists.”
Storrer will also oversee the continued expansion of Strand Life Sciences’ genomics software business. He will also be responsible for the continued development and marketing of Strand’s precision medicine products in India.
Storrer joined Strand in July 2014 as president of North America. Prior to this, he was president and CEO of Genomind, a personalised medicine company, and CEO of Medecision, a population health-management solutions company.